Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

Pipette Tips

November 8, 2011 11:04 am | Product Releases | Comments

Beckman Coulter Inc. offers Biomek P1000 Span-8 pipette tips for the Biomek NXP and FXP laboratory automation workstations, which allow users to inspect aspirated volumes.

Solvent-Resistant Labels

November 8, 2011 11:02 am | Drug Discovery & Development, Drug Discovery & Development | Product Releases | Comments

CILS International’s CILS-8200S solvent-resistant surface coating ensures variable data remains clear and legible when exposed to methanol, ethanol, acetone, IPA and THF.

Ductless Fume Hoods

November 8, 2011 10:59 am | Product Releases | Comments

The Purair 5 Ductless Fume Hoods from Air Science USA are available in 24 in, 36 in or 48 in models.


Cell Culture Roller Bottles

November 8, 2011 10:58 am | Drug Discovery & Development, Drug Discovery & Development | Product Releases | Comments

Thermo Fisher Scientific Inc.’s Nunc Roller Bottles are designed for cell culture applications in the production of vaccines and monoclonal antibody-based biopharmaceuticals.

Syringe Filter

November 8, 2011 7:06 am | Drug Discovery & Development | Product Releases | Comments

Pall Corporation introduced the Pall Acrodisc MS Syringe Filter the first syringe filter certified for low extractables in high-performance liquid chromatography/mass spectrometry applications.


Preparative Ultracentrifuges

November 8, 2011 6:28 am | Product Releases | Comments

The Optima X Series preparative ultracentrifuges from Beckman Coulter, Inc. incorporate an array of contemporary technical features to enhance the user experience, increase productivity, and reduce costs.


LEO Pharma Installs CM3

November 8, 2011 6:18 am | News | Comments

Freeslate, Inc. announced that LEO Pharma has selected Freeslate’s Core Module 3 high-throughput research platform for evaluating solubility of drugs in various viscous formulations and for preparing samples for characterization and analysis.


MAP Pharma Earns $11M in Q3

November 8, 2011 6:09 am | News | Comments

MAP Pharmaceuticals Inc. said that it made a profit in the third quarter after receiving two payments from its partner, Allergan Inc. MAP said it earned $11.2 million, or 35 cents per share, and it reported $23.9 million in revenue.


Long-term Humira Study Shows Improvement in AS

November 8, 2011 6:05 am | News | Comments

Abbott announced five-year results from the open-label extension of the ATLAS study, which evaluated the long-term impact of treatment with Humira on disease activity, including spinal mobility in patients with active ankylosing spondylitis.


FDA Approves New Erbitux Indication

November 8, 2011 5:52 am | News | Comments

The U.S. Food and Drug Administration approved Erbitux for use with chemotherapy to treat patients with late-stage head and neck cancer. Combined with chemotherapy, Erbitux extended the lives of those receiving the treatment combination.


Nabi Exploring Options After NicVAX Failure

November 8, 2011 5:47 am | News | Comments

Nabi Biopharmaceuticals said it will explore strategic options after its anti-smoking vaccine NicVAX failed in a second late-stage clinical trial. The company said there was not a significant difference between NicVAX and a dummy shot.


Momenta Income Up 88%

November 8, 2011 5:45 am | News | Comments

Momenta Pharmaceuticals Inc. said its profit nearly doubled in the third quarter compared to a year ago, when it made a $35 million payment to its partner Sandoz.


Lilly and Amylin End Diabetes Partnership

November 8, 2011 5:43 am | by Tom Murphy | News | Comments

The drugmakers Eli Lilly and Co. and Amylin Pharmaceuticals Inc. said that they were ending their long-standing agreement to develop diabetes drugs. The companies also said they were resolving a lawsuit filed earlier this year.


Cell Culture Flasks

November 7, 2011 12:08 pm | Product Releases | Comments

Cell culture flasks combine high-pressure molded 100% USP Class VI virgin crystal polystyrene with a low-pressure gas plasma surface treatment.

Barcoded Tubes

November 7, 2011 12:07 pm | Product Releases | Comments

Thermo Fisher Scientific Inc.’s Matrix Amber 2D barcoded tubes are available in 0.5 and 1.0 mL sizes.


You may login with either your assigned username or your e-mail address.
The password field is case sensitive.